Our Pricing

Mounjaro Moldgreen: Expert Weight Loss Support from a UK-Registered Pharmacy

Published: 6 October 2026

Residents of Moldgreen seeking Mounjaro Moldgreen weight loss treatment can access prescription tirzepatide injections through Cured Pharmacy's fully regulated UK service. Our GPhC-registered pharmacy (9012511) connects you with UK prescribers who assess your suitability for Mounjaro, ensuring safe, evidence-based weight management from the comfort of your Moldgreen home. With transparent pricing from £124.99 and discreet delivery across West Yorkshire, we make accessing this clinically proven treatment straightforward and confidential.

Why Choose Mounjaro Moldgreen Through Cured Pharmacy?

Accessing Mounjaro Moldgreen through Cured Pharmacy offers distinct advantages for local residents. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription, ensuring compliance with MHRA guidelines and patient safety standards. Unlike high-street pharmacies, we provide transparent upfront pricing at £124.99 before your consultation begins, eliminating surprise costs [1].

Our online consultation takes under three minutes and is reviewed by UK-registered prescribers who specialise in weight management. If Mounjaro is deemed clinically appropriate for you, your prescription is fulfilled using genuine UK-licensed tirzepatide manufactured by Eli Lilly. We guarantee 100% discreet packaging, with delivery direct to your Moldgreen address, and offer £20 off your first order using code Weightlossnew.

How Mounjaro Moldgreen Treatment Works for Weight Loss

Mounjaro Moldgreen prescriptions contain tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. This medication works by mimicking natural hormones that regulate appetite and blood sugar, helping you feel fuller for longer and reducing calorie intake [2]. In the landmark SURPASS-2 trial, participants using tirzepatide achieved an average weight reduction of up to 15% of their body weight over 40 weeks, significantly outperforming other GLP-1 therapies [3].

Treatment begins with a low 2.5mg dose administered once weekly via subcutaneous injection, gradually increasing every four weeks to optimise efficacy and minimise side effects. Most patients in Moldgreen tolerate the escalation well, with our clinical team providing ongoing support throughout your treatment journey.

Dosing Schedule for Mounjaro Moldgreen Patients

The standard titration schedule starts at 2.5mg weekly for four weeks, then increases to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg, each maintained for at least four weeks. This gradual approach reduces gastrointestinal side effects such as nausea and vomiting, which are most common during initial weeks [4]. Your prescriber will tailor the schedule based on your tolerance and weight loss progress.

Mounjaro Moldgreen Eligibility and Prescription Process

To qualify for Mounjaro Moldgreen treatment, you must have a body mass index (BMI) of 30 or above, or 27 or above with at least one weight-related comorbidity such as hypertension or type 2 diabetes. Our online consultation collects your medical history, current medications, and weight management goals, which are then reviewed by a UK prescriber within hours [5].

Mounjaro is a prescription-only medicine, meaning you cannot purchase it over the counter. Our prescribers assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. If approved, your prescription is dispensed from our GPhC-registered pharmacy and dispatched the same day for next-day delivery across Moldgreen.

Mounjaro Moldgreen Pricing and How to Save

Cured Pharmacy offers Mounjaro Moldgreen at £124.99 per four-week supply, providing some of the most competitive pricing in the UK. This transparent cost includes your medication, prescriber consultation, and discreet home delivery. New patients can Save £20 using code Weightlossnew at checkout, reducing your first month to £124.99.

We never require upfront subscriptions or hidden fees. You control your treatment schedule, ordering as needed without automatic renewals. Our lowest price guarantee ensures you receive genuine tirzepatide at the best available UK rate, with full pharmacist support included at no extra charge.

Comparing Mounjaro Moldgreen Costs Across UK Pharmacies

While high-street pharmacies often quote variable pricing dependent on stock availability, Cured Pharmacy maintains consistent £124.99 pricing year-round. This predictability helps Moldgreen residents budget effectively for long-term weight management, which typically spans six to twelve months for optimal results [6].

Common Side Effects of Mounjaro Moldgreen Treatment

The most frequently reported side effects of Mounjaro Moldgreen prescriptions include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. These gastrointestinal symptoms are typically mild to moderate and diminish as your body adapts to the medication, usually within the first four to eight weeks [7].

Less common but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients using other diabetes medications). If you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction, discontinue use and seek immediate medical attention. Our pharmacist team is available at (+44) 116 4646009 to discuss any concerns about your Mounjaro Moldgreen treatment.

Mounjaro Moldgreen: Long-Term Weight Management Success

Clinical evidence demonstrates that Mounjaro Moldgreen patients achieve sustained weight loss when combined with lifestyle modifications including a reduced-calorie diet and increased physical activity. The SURMOUNT-1 trial showed that 89% of participants maintained at least 5% weight loss at 72 weeks, with many achieving 15-20% reductions [8].

Long-term success requires ongoing commitment to healthier eating patterns and regular exercise. Our clinical team provides guidance on optimising your Moldgreen weight loss journey, including dietary advice and strategies to prevent weight regain after treatment completion. Subject to prescriber approval, many patients continue Mounjaro for 12-18 months to reach and maintain their target weight.

Monitoring Progress with Mounjaro Moldgreen

We recommend weighing yourself weekly at the same time of day and tracking measurements such as waist circumference. Your prescriber may request follow-up consultations every 12 weeks to assess efficacy and adjust dosing. If you do not achieve at least 5% weight loss after 16 weeks at the maximum tolerated dose, your prescriber may recommend discontinuing Mounjaro and exploring alternative treatments available through Cured Pharmacy.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of product characteristics. GOV.UK. [accessed 6 October 2026]
2. Nauck, M. A., & D'Alessio, D. A. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21(1), 169. [accessed 6 October 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 6 October 2026]
4. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: The SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545. [accessed 6 October 2026]
5. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. [accessed 6 October 2026]
6. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 29(10), 2473-2483. [accessed 6 October 2026]
7. Aroda, V. R., Rosenstock, J., Terauchi, Y., et al. (2019). PIONEER 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes. Diabetes Care, 42(9), 1724-1732. [accessed 6 October 2026]
8. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 6 October 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 6 October 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 6 October 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 6 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.